FibroGen (FGEN) Debt/EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 0.92 | 1.17 | 0.21 | -0.28 | 1.94 | 1.92 | |||
| Changes by years, y/y, % | -77% | +28% | -82% | -231% | -796% | -13.2% | |||
FibroGen. Debt/EBITDA
FibroGen. Debt/EBITDA, changes, %
FibroGen (FGEN) Debt/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| Debt/EBITDA | -0.24 | -0.39 | 0.76 | 1.94 | 2.75 | 1.92 | ||
| Changes by years, y/y, % | +829% | +1 281% | +129% | -1 064% | -1 227% | |||
| Changes by quarters, q/q, % | +21% | +60% | -295% | +155% | +42% | |||